Balchem CorpBCPC
Price$164.96Intrinsic value$174.506% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.1B+13.9% YoYTTM through 30 Jun 2026
Net Income $164.4M+28.0% YoYTTM through 30 Jun 2026

Margins

Current
Gross Margin37.3%
EBITDA Margin24.8%
Operating Margin18.8%
Net Margin15.1%

Returns

12.3%ROE
9.3%ROA
11.7%ROIC

Balance Sheet Health

Debt / Equity0.13x
Current Ratio2.55x
Net Debt$96.1M
Cash & Equivalents$63.2M

Quality Metrics

Altman Z-Score10.63
Piotroski F-Score8 / 9
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $1B
Diluted EPS$5.09TTM
'19'20'21'22'23'24'25
FY2025: $4.75

Dividend

$0.96Per share, FY20250.57%Yield9 yrsStreak+10.6%5-yr growth

Capital Allocation

R&D Spend$20M
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.